NOVAVAX INC's ticker is and the CUSIP is 670002901. A total of 4 filers reported holding NOVAVAX INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,638 | +150.5% | 1,193,200 | +157.1% | 0.01% | +133.3% |
Q2 2023 | $3,448 | -45.7% | 464,100 | -49.3% | 0.00% | -50.0% |
Q1 2023 | $6,346 | -28.7% | 915,800 | +5.8% | 0.01% | -40.0% |
Q4 2022 | $8,895 | -99.9% | 865,300 | +124.3% | 0.01% | +25.0% |
Q3 2022 | $7,021,000 | -51.1% | 385,800 | +38.3% | 0.01% | -46.7% |
Q2 2022 | $14,348,000 | -46.1% | 279,000 | -22.7% | 0.02% | -37.5% |
Q1 2022 | $26,595,000 | -47.9% | 361,100 | +1.1% | 0.02% | -53.8% |
Q4 2021 | $51,090,000 | +89.6% | 357,100 | +185.9% | 0.05% | +108.0% |
Q3 2021 | $26,948,000 | +9.0% | 124,900 | +7.3% | 0.02% | +4.2% |
Q2 2021 | $24,712,000 | -17.7% | 116,400 | +6929.0% | 0.02% | -55.6% |
Q1 2021 | $30,024,000 | +24.4% | 1,656 | -23.5% | 0.05% | +74.2% |
Q4 2020 | $24,130,000 | +15.2% | 2,164 | +11.9% | 0.03% | +6.9% |
Q3 2020 | $20,954,000 | +79.7% | 1,934 | +38.2% | 0.03% | +52.6% |
Q2 2020 | $11,660,000 | +380.2% | 1,399 | -21.8% | 0.02% | +375.0% |
Q1 2020 | $2,428,000 | +265.7% | 1,788 | +7.1% | 0.00% | +300.0% |
Q4 2019 | $664,000 | +122.8% | 1,669 | +180.5% | 0.00% | 0.0% |
Q3 2019 | $298,000 | -38.0% | 595 | -27.7% | 0.00% | 0.0% |
Q2 2019 | $481,000 | – | 823 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 1,196,100 | $8,659,764 | 0.03% |
NATIONAL BANK OF CANADA /FI/ | 12,782 | $9,062,438 | 0.01% |
SIMPLEX TRADING, LLC | 1,193,200 | $8,638 | 0.01% |
IMC-Chicago, LLC | 508,100 | $3,678,644 | 0.00% |
JANE STREET GROUP, LLC | 585,400 | $4,238,296 | 0.00% |
CTC LLC | 1,548 | $1,120,752 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 485,000 | $3,511,400 | 0.00% |